Impact of encorafenib on survival of patients with BRAF(V600E)-mutant metastatic colorectal cancer in a real-world setting

PURPOSE: Patients with BRAF(V600E)-mutant metastatic colorectal cancer (mCRC) have a dismal prognosis. The best strategies in these patients remain elusive. Against this background, we report the clinical course of patients with BRAF(V600E)-mutant mCRC to retrieve the best treatment strategy. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Zurloh, M., Goetz, M., Herold, T., Treckmann, J., Markus, P., Schumacher, B., Albers, D., Rink, A., Rosery, V., Zaun, G., Kostbade, K., Pogorzelski, M., Ting, S., Schmidt, H., Stiens, R., Wiesweg, M., Schuler, M., Kasper, Stefan, Virchow, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587317/
https://www.ncbi.nlm.nih.gov/pubmed/37466791
http://dx.doi.org/10.1007/s00432-023-05141-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587317/
https://www.ncbi.nlm.nih.gov/pubmed/37466791
http://dx.doi.org/10.1007/s00432-023-05141-y

Ejemplares similares